Stay updated with breaking news from Alpine Immune Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Alpine Immune Sciences (NASDAQ:ALPN – Free Report) had its price objective boosted by Oppenheimer from $14.00 to $22.00 in a research report released on Monday, MarketBeat reports. Oppenheimer currently has an outperform rating on the biotechnology company’s stock. Several other research firms have also issued reports on ALPN. HC Wainwright restated a buy rating and […]
Alpine Immune Sciences (NASDAQ:ALPN – Free Report) had its target price lifted by Oppenheimer from $14.00 to $22.00 in a report issued on Monday, MarketBeat.com reports. They currently have an outperform rating on the biotechnology company’s stock. Other research analysts also recently issued research reports about the company. Wedbush reiterated an outperform rating and issued […]
Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report)’s stock price was down 4.2% during mid-day trading on Tuesday . The company traded as low as $12.27 and last traded at $12.31. Approximately 16,561 shares were traded during trading, a decline of 89% from the average daily volume of 148,825 shares. The stock had previously […]
SEATTLE--(BUSINESS WIRE)--Sep 5, 2023--
HC Wainwright reiterated their buy rating on shares of Alpine Immune Sciences (NASDAQ:ALPN – Free Report) in a research note released on Thursday, Benzinga reports. They currently have a $17.00 price target on the biotechnology company’s stock. Separately, Wedbush boosted their target price on Alpine Immune Sciences from $17.00 to $19.00 and gave the stock […]